- Home
- SNY vs NEA Comparison
SNY vs NEA Comparison
Compare SNY & NEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- NEA
- Stock Information
- Founded
- SNY 1994
- NEA 2002
- Country
- SNY France
- NEA United States
- Employees
- SNY N/A
- NEA N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- NEA Finance/Investors Services
- Sector
- SNY Health Care
- NEA Finance
- Exchange
- SNY Nasdaq
- NEA Nasdaq
- Market Cap
- SNY 113.4B
- NEA 3.4B
- IPO Year
- SNY N/A
- NEA N/A
- Fundamental
- Price
- SNY $47.17
- NEA $11.25
- Analyst Decision
- SNY Buy
- NEA
- Analyst Count
- SNY 4
- NEA 0
- Target Price
- SNY $61.50
- NEA N/A
- AVG Volume (30 Days)
- SNY 2.7M
- NEA 803.4K
- Earning Date
- SNY 10-24-2025
- NEA 01-01-0001
- Dividend Yield
- SNY 3.40%
- NEA 4.23%
- EPS Growth
- SNY 118.56
- NEA N/A
- EPS
- SNY 8.65
- NEA N/A
- Revenue
- SNY $53,714,621,258.00
- NEA N/A
- Revenue This Year
- SNY $1.53
- NEA N/A
- Revenue Next Year
- SNY $7.06
- NEA N/A
- P/E Ratio
- SNY $5.43
- NEA N/A
- Revenue Growth
- SNY 15.65
- NEA N/A
- 52 Week Low
- SNY $44.73
- NEA $9.20
- 52 Week High
- SNY $60.12
- NEA $11.37
- Technical
- Relative Strength Index (RSI)
- SNY 44.75
- NEA 58.78
- Support Level
- SNY $46.50
- NEA $10.92
- Resistance Level
- SNY $47.33
- NEA $11.41
- Average True Range (ATR)
- SNY 0.66
- NEA 0.09
- MACD
- SNY -0.13
- NEA 0.01
- Stochastic Oscillator
- SNY 40.82
- NEA 61.11
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About NEA Nuveen AMT-Free Quality Municipal Income Fund of Beneficial Interest Par Value $.01
Nuveen AMT-Free Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax and the alternative minimum tax applicable to individuals, by investing in an actively managed portfolio of tax-exempt municipal securities. The company invest in Transportation, Utilities, Healthcare, Education and Civics, and other sectors, with maximum investment in Transportation.